2Limper M, de Kruif MD, Duits A J, et al. The diagnostic role of procalcitonin and other biomarkers in discriminating infectious from non - infectious fever [ J ]. Infect, 2010, 60 (6) :409-416.
3Vandack N, Stephan H, Jean DG, et al. Use of procalcitonin to shorten antibiotic treatment duration in septic patients [ J ]. Am Respir Crit Care Med,2008,177 (5) :498-505.
4Heart Protection Study Collaborative Group, Jonathan Emberson, Derrick Bennett, et al. C-reactive protein concentration and the vascular benefits of statin therapy: an analysis of 20,536 patients in the heart protection study [ J ]. Lancet, 2011,377 (9764) :469-476.
5Edwards JR,Peterson KD,Mu Y,et al.National Healthcare Safety Network(NHSN)report:data summary for2006 through 2008,issued December 2009.[J].Am J Infect Control,2009(10):783-805.
6Schoenfeld AJ,Carey PA,Cleveland AR,et al.Patient factors,comorbidities,and surgical characteristics that increase mortality and complication risk after spinal arthrodesis:a prognostic study based on 5,887 patients.[J].Spine J,2013(10):1171-1179.
7Pasupuleti L V,Sifri Z C,Mohr A M.Is extended antibiotic prophylaxis necessary after penetrating trauma to the thoracolumbar spine with concomitant intraperitoneal injuries?[J].Surg Infect(Larchmt),2014(1):8-13.
8Yang YH,Zheng J,Lou SL.Causes and managements of postoperative complications after degenerative scoliosis treatments with internal fixation.[J].Int J Clin Exp Med,2014(11):4300-4307.
9Glotzbecker MP,Riedel MD,Vitale MG,et al.What's the evidence?Systematic literature review of risk factors and preventive strategies for surgical site infection following pediatric spine surgery.[J].J Pediatr Orthop,2013(5):479-487.
10Abdul-Jabbar A,Takemoto S,Weber MH,et al.Surgical site infection in spinal surgery:description of surgical and patient-based risk factors for postoperative infection using administrative claims data.[J].Spine(Phila Pa1976),2012(15):1340-1345.
